Why Immune Balancing is Better than Boosting

Why Immune Balancing is Better than Boosting

How PectaSol-C Works to Optimize your Immune System 

In today’s global climate, it’s critical to optimize and balance immune function. But what exactly does this mean?

It means we support the immune system so it can quickly detect and neutralize invaders—without going overboard and attacking the body.

This is precisely why PectaSol-C® Modified Citrus Pectin is so essential. Extensive research shows how this advanced nutraceutical ingredient works on multiple levels to regulate and optimize immune function:

  • Promotes healthy immune cell activity*
  • Maintains balanced immune responses*
  • Supports a healthy microbiome*

Immune Balancing vs. Boosting

Today, it’s important to know the difference between natural compounds that simply boost immune activity, like echinacea, for example—and multi-dimensional ingredients and formulas that are proven to balance, modulate and fine-tune immune responses.

This latter category is vital. While immune-boosters like echinacea can send the immune system into overdrive, natural immune-modulating agents work instead to train and optimize immune responses.

This means your immune system can work smarter, not harder.

Immune modulators support robust immune activity, while at the same time, preventing immune over-reactions—ensuring that vital organs and tissues stay healthy.

With its multifaceted, proven immune benefits, PectaSol-C is at the top of the immune modulator list.

Promotes Optimal Immune Cell Activity

PectaSol-C shows powerful immune support properties. One published study showed PectaSol-C promotes Natural Killer (NK) cell activity and functionality by up to 40%. NK cells are critical immune cells that work to defend against a wide array of invaders.1

Balances Immune Response

PectaSol-C also balances the immune system, so it doesn’t go haywire. It does this by blocking the rogue protein, galectin-3 (Gal-3). Excessive Gal-3 can trigger a cascade of overactive immune responses, with severe impacts on the lungs, kidneys, and other vital organs.2 By blocking Gal-3, PectaSol-C works to calm these responses, promoting optimal immune function and overall organ health.

Exposes Invaders

Gal-3 can also allow invaders to hide in the body without being detected by immune cells. PectaSol-C disrupts Gal-3 networks on cell membranes and presents invaders to the immune system, for swift action.3

Microbiome Support

Gut health and microbiome integrity play critical roles in immunity. Research shows PectaSol-C offers important benefits as a prebiotic fiber, helping to support healthy microbiota and overall GI tract integrity.4

The Strategy of Synergy

One of PectaSol-C’s most remarkable benefits is its proven ability to enhance the benefits and effects of other agents—natural and conventional. Because PectaSol-C disrupts Gal-3, it can help other formulas and ingredients work better.5

For this reason, PectaSol-C can be referred to as the “arrowhead”— allowing other immune botanicals, formulas, and compounds to reach their targets with higher speed and accuracy.*

Immunity and Beyond

A well-trained immune system is our lifeline for longevity—but the benefits of PectaSol-C don’t end here.

PectaSol-C delivers essential support to our most critical areas of health, because of its unique ability to block the actions of Gal-3. Over 50 published studies show PectaSol-C’s unparalleled benefits for cellular health and oncology support, safe heavy metal and toxin removal, cardiovascular and kidney health, neurological support, and more.*

This is why researchers, healthcare providers, and everyday health seekers around the world are increasingly interested in PectaSol-C Modified Citrus Pectin—a trusted cornerstone of long-term health and immunity.*

Sources:

1. Ramachandran C, et al. BMC Complement Altern Med. 2011;11:59. 

2. Chen YJ, et al. Am J Pathol. 2018;188(4):1031–1042.

3. Díaz-Alvarez L, Ortega E. Mediators Inflamm. 2017;2017:9247574. 

4. Di R, Vakkalanka MS, Onumpai C, et al. Food Chem. 2017;227:245–254.5. Hossein, G, et al. Cancer Med. 2019; 8: 4315– 4329.